Euglena Overview
- Founded
-
2005
- Status
-
Public
- Employees
-
1,070
- Stock Symbol
-
2931
- Investments
-
12
- Share Price
-
$5.30
- (As of Friday Closing)
Euglena General Information
Description
euglena Co Ltd is a biotechnology company that researches, develops, produces, and markets microalgae. The company focuses on commercializing its algae research for a variety of uses, including functional foods and cosmetics. Euglena also researches ways to use its microalgae for carbon capture and biofuel production.
Contact Information
- G-Base Tamachi 2nd Floor
- 5-29-11 Shiba, Minato-ku
- Tokyo, 108-0014
- Japan
Euglena Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $5.30 | $5.24 | $5.19 - $8.22 | 117M | 632K | -$0.20 |
Euglena Financials Summary
|
In Thousands, USD |
TTM 30-Jun-2023 | FY 2022 31-Dec-2022 | FY 2021 30-Sep-2021 | FY 2020 30-Sep-2020 |
|---|---|---|---|---|
| EV | 719,218 | 961,125 | 994,321 | 744,549 |
| Revenue | 332,229 | 337,791 | 216,665 | 123,480 |
| EBITDA | 9,884 | 9,976 | (22,730) | (6,569) |
| Net Income | (22,732) | (20,332) | (22,616) | (13,785) |
| Total Assets | 420,021 | 436,814 | 572,282 | 145,273 |
| Total Debt | 175,683 | 169,463 | 230,365 | 35,623 |
Euglena Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Euglena Comparisons
Industry
Financing
Details
000000
Euglena Competitors (1)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| 000000 | Formerly VC-backed | Chassieu, France | 00 | 000.00 | 000000 - 000 | 000.00 |
Euglena Patents
Euglena Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| JP-2023091546-A | Feed for marine invertebrates, method for producing feed for marine invertebrates, method for cultivating marine invertebrates, method for promoting shell length, and method for improving fatty acid content | Pending | 20-Dec-2021 | ||
| JP-2023077876-A | Genome-edited microalgae, method for modifying genome of microalgae, method for breeding microalgae, and method for producing compound or algal powder | Pending | 25-Nov-2021 | ||
| JP-2023076299-A | Food composition for life extension | Active | 22-Nov-2021 | ||
| JP-7258990-B1 | Food composition for life extension | Active | 22-Nov-2021 | 0 | |
| JP-2023020773-A | Crickets, method for breeding crickets, cricket feed, astaxanthin-enhanced crickets, and docosahexaenoic acid-enhanced crickets | Pending | 29-Jul-2021 |
Euglena Executive Team (11)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Akihiko Nagata | Chief Executive Officer & Board Member | ||
| Izumo Mitsuru | Founder, President & Board Member | ||
| Yasuhiro Fukutomi | Professional Officer Chief Strategy Officer | ||
| Suzuki Kengo | Co-Founder & Executive Officer Chief Technology Officer | ||
| Daisuke Susa | Executive Officer & Chief Administrative Officer |
Euglena Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Akihiko Nagata | Euglena | Chief Executive Officer & Board Member | 000 0000 |
| Etsuko Okajima | Euglena | Board Member & Executive | 000 0000 |
| Masahiro Kotosaka | Euglena | Board Member | 000 0000 |
| Mirai Murakami | Euglena | Board Member | 000 0000 |
| Mochizuki Aiko | Self | Board Member | 000 0000 |
Euglena Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Euglena Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Euglena Investments & Acquisitions (12)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 | 01-Feb-2022 | 0000000000 | Food Products | 00000 000 | |
| 00000 | 15-Dec-2021 | 00000 0000 | 00.000 | Biotechnology | 00000000 |
| 0'000 | 01-Feb-2021 | 0000000000 | 00000 | Food Products | |
| 0000000 | 02-Mar-2020 | 00000 0000 | 00.000 | Clinics/Outpatient Services | |
| Glocalink Singapore | 08-Aug-2019 | Joint Venture | Consumer Finance | 000000 00 |
Euglena Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Frembassy | Food Products | Tokyo, Japan | 2015 |
| 000000000 | Laboratory Services (Healthcare) | Tokyo, Japan | 0000 |
Euglena ESG
Risk Overview
Risk Rating
Updated April, 21, 2023
35.21 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
00.00
Management
Management is related to actions taken to manage ESG issues
00.00
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
00 of 15,491
Rank
Percentile
Household Products
Industry
00 of 104
Rank
Percentile
Personal Products
Subindustry
00 of 78
Rank
Percentile
